Given that dysregulated RTK signaling drives gliomagenesis in part by reprogramming cellular metabolism (e.g. glycolysis and cholesterol uptake) by engaging Akt-mTOR signaling [50], our findings underscore the complex crosstalk between metabolism and RTK signaling in GBM pathogenesis. Here, MTOR is linked to glioblastoma.